SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-05-225836
Filing Date
2005-11-14
Accepted
2005-11-14 16:19:01
Documents
5
Period of Report
2005-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 441507
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER dex311.htm EX-31.1 9321
3 CERTIFICATION OF PRINCIPAL FINANCIAL & ACCOUNTING OFFICER dex312.htm EX-31.2 9216
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER dex321.htm EX-32.1 4057
5 CERTIFICATION OF PRINCIPAL FINANCIAL & ACCOUNTING OFFICER dex322.htm EX-32.2 4458
  Complete submission text file 0001193125-05-225836.txt   469850
Mailing Address
Business Address 1124 COLUMBIA STREET SUITE 130 SEATTLE WA 98104 2062626200
XCYTE THERAPIES INC (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50626 | Film No.: 051201789
SIC: 2834 Pharmaceutical Preparations